Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Zahariy Krastev"'
Autor:
Vladimir E. Panov, Assya Krasteva, Adriana Z. Krasteva, Aneta Ivanova, Anton Panov, Zahariy Krastev
Publikováno v:
Journal of IMAB, Vol 20, Iss 1, Pp 464-468 (2014)
Objective: Calprotectin is a calcium binding heterocomplex protein which appear to have regulatory functions in the inflammatory process. Epithelial cells which expressing calprotectin are more resistant to bacterial invasion . In acute phase inflamm
Externí odkaz:
https://doaj.org/article/b06940974ac8469d83db70c5de1d0584
Autor:
Assya Krasteva, Vladimir E. Panov, Dejan Jelev, Krasimir Antonov, Aneta Ivanova, Zahariy Krastev
Publikováno v:
Journal of IMAB, Vol 19, Iss 4, Pp 355-358 (2013)
Hepatitis B virus is the most important infectious hazard in dental profession. Vectors of HBV infection are not only blood, but also saliva, nasopharyngeal secretions, crevicular fluid.The aim of the study was to evaluate serum and salivary HBV DNA
Externí odkaz:
https://doaj.org/article/91cee5eb45b94ad9b48891b68a5ce15b
Publikováno v:
Journal of IMAB, Vol 19, Iss 3, Pp 442-447 (2013)
Introduction: IP-10 it has been studied as a predictor of treatment response in chronic HCV infected patients. The data for the HBV infection are not enough.Aim: To compare IP-10 levels in patients with chronic HBV /CHB/ and HCV infection /CHC/ and t
Externí odkaz:
https://doaj.org/article/6589e6c790a741f99d6c7e776c027072
Publikováno v:
Journal of IMAB, Vol 17, Iss 1, Pp 154-157 (2011)
Objective: IFN-based therapy induces long-term remission in ~20% of CHB-patients. Identification of predictors of treatment response can facilitate the clinical decision. Methods: 168 CHB-patients treated with IFN-based therapy were studied. Predicto
Externí odkaz:
https://doaj.org/article/6530c814ad4043a3a9c5c6acb3d4a629
Autor:
Krasimir Antonov, Dimitar Popov, Radina Ivanova, Asen Aleksiev, Donika Krasteva, Deian Jelev, Zahariy Krastev, L. Mateva
Publikováno v:
Journal of Medical and Dental Practice. 6:962-967
Publikováno v:
Journal of IMAB, Vol 17, Iss 1, Pp 197-199 (2011)
Objective: The combined PEG-IFN alpha and RBV therapy achieved SVR in 40 - 50% of patients infected with HCV genotype 1. Identification of virological and host paramemeters predicting SVR will be useful to tailor therapy. Methods: 71 patients with ch
Externí odkaz:
https://doaj.org/article/082bcb1b555047e6a53d1d61a667ebce
Autor:
Donika Krasteva, Radosveta Tomova, Dejan Jelev, Krasimir Antonov, Lyudmila Mateva, Zahariy Krastev
Publikováno v:
Journal of Medical and Dental Practice. 5:897-907
Autor:
Yavor Pindev, Zahariy Krastev
Publikováno v:
Journal of Medical and Dental Practice. 5:890-896
Autor:
Donika Krasteva, Zlatimir Kolarov, Zoya Spassova, Krassimir Antonov, Rasho Rashkov, Georgi Mihailov, Branimir Spassov, Zahariy Krastev, L. Mateva, Deian Jelev, Rossen Nikolov
Publikováno v:
Journal of Medical and Dental Practice. 6:831-836
Publikováno v:
Journal of IMAB, Vol 17, Iss 1, Pp 152-153 (2011)
Objective: HBV-infection is intermediate-endemic in Bulgaria. There is a trend for decreasing of HBsAg-carrier rate in the last decades, but prevalence remains higher in some specific ethnic communities. Current data regarding high-endemic sources of
Externí odkaz:
https://doaj.org/article/c70ae812e75548bf97209b3fdc884d6c